Stem Cells: An Alternative Therapy for COVID-19 and Cytokine Storm provides mechanistic insights into the role of stem cells to combat COVID-19 outbreak and other pathologies where cytokines storm is the cause of concern for e.g., radiation exposure, multiple organ failure and sepsis. There has been an increase in number of cases of new diseases in the last decade, including mucormycosis, Zika virus, H1N1 influenza virus, among others. These diseases can be characterized by the induction of cytokine storm, which is mainly responsible for morbidity and mortality. Stem cell therapy has emerged…mehr
Stem Cells: An Alternative Therapy for COVID-19 and Cytokine Storm provides mechanistic insights into the role of stem cells to combat COVID-19 outbreak and other pathologies where cytokines storm is the cause of concern for e.g., radiation exposure, multiple organ failure and sepsis. There has been an increase in number of cases of new diseases in the last decade, including mucormycosis, Zika virus, H1N1 influenza virus, among others. These diseases can be characterized by the induction of cytokine storm, which is mainly responsible for morbidity and mortality. Stem cell therapy has emerged as a potential treatment for viral diseases, including, but not limited to, COVID-19. Interestingly, clinical trials in patients with COVID-19 complications depicted faster recovery in patients post mesenchymal stem cells therapy owing to the decreased cytokines levels, anti-viral effects and regeneration of the infected tissue.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
1. Targets of SARS CoV 2: Therapeutic Implications for COVID 19 2. COVID 19 Biology: Cytokine Storms and Their Implications 3. Comparative Clinical Investigation of Blood Profiling in COVID 19 Patients 4. SARS CoV 2 Associated Complications 5. COVID 19 Diagnostic Approaches and Modern Mesenchymal Stem Cell based Treatment 6. Modulation of Pentose Phosphate Pathway Augments the Efficacy of 2 deoxy D glucose in COVID 19 Management 7. Therapeutic Landscape of SARS CoV 2 8. Pharmacotherapeutics for Cytokine Storm in COVID 19 9. Clinical Investigation of COVID 19 Prevention and Treatment 10. Potential Therapeutic Landscape of COVID 19: Molecular Targets, Repurposed Drugs, and Nano and Cell based Intervention 11. Medical Care for SARS CoV 2 12. Therapeutic Approaches for Opportunistic Infection Post COVID 19 13. Focusing on the Cytokine Storm in the Battle Against COVID 19: The Rising Role of Mesenchymal derived Stem Cells 14. Cytokine Storm in COVID 19 and Other Diseases: Emerging Therapeutic Interventions 15. Stem Cells as Therapeutics and Their Implications in Cytokine Storm in COVID 19 16. Visualizing Chemical Functionality and Structural Insights into SARS CoV 2 Proteins 17. Mesenchymal Stromal Cells and Pleiotropic Therapeutic Advantages in COVID 19 Management 18. Mesenchymal Stem Cells Role in Tuberculosis Pathogenesis and Persistence 19. Radiosensitivity of Cancer Stem Cells Holds Promise for the Outcome in Radiotherapy and COVID 19 Infections 20. Immunomodulatory Therapeutic Potential of Mesenchymal Stem Cells in COVID 19 Pathogenesis 21. Clinical Limitations of Stem Cell Therapy 22. Clinical Limitations in Stem Cell Therapy 23. Stem Cell Based Products and the Regulatory Hurdle Race 24. Implications of Stem Cell Therapy on the Socio Scientific Community
1. Targets of SARS CoV 2: Therapeutic Implications for COVID 19 2. COVID 19 Biology: Cytokine Storms and Their Implications 3. Comparative Clinical Investigation of Blood Profiling in COVID 19 Patients 4. SARS CoV 2 Associated Complications 5. COVID 19 Diagnostic Approaches and Modern Mesenchymal Stem Cell based Treatment 6. Modulation of Pentose Phosphate Pathway Augments the Efficacy of 2 deoxy D glucose in COVID 19 Management 7. Therapeutic Landscape of SARS CoV 2 8. Pharmacotherapeutics for Cytokine Storm in COVID 19 9. Clinical Investigation of COVID 19 Prevention and Treatment 10. Potential Therapeutic Landscape of COVID 19: Molecular Targets, Repurposed Drugs, and Nano and Cell based Intervention 11. Medical Care for SARS CoV 2 12. Therapeutic Approaches for Opportunistic Infection Post COVID 19 13. Focusing on the Cytokine Storm in the Battle Against COVID 19: The Rising Role of Mesenchymal derived Stem Cells 14. Cytokine Storm in COVID 19 and Other Diseases: Emerging Therapeutic Interventions 15. Stem Cells as Therapeutics and Their Implications in Cytokine Storm in COVID 19 16. Visualizing Chemical Functionality and Structural Insights into SARS CoV 2 Proteins 17. Mesenchymal Stromal Cells and Pleiotropic Therapeutic Advantages in COVID 19 Management 18. Mesenchymal Stem Cells Role in Tuberculosis Pathogenesis and Persistence 19. Radiosensitivity of Cancer Stem Cells Holds Promise for the Outcome in Radiotherapy and COVID 19 Infections 20. Immunomodulatory Therapeutic Potential of Mesenchymal Stem Cells in COVID 19 Pathogenesis 21. Clinical Limitations of Stem Cell Therapy 22. Clinical Limitations in Stem Cell Therapy 23. Stem Cell Based Products and the Regulatory Hurdle Race 24. Implications of Stem Cell Therapy on the Socio Scientific Community
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497